Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Tekweld Solutions, Inc. for the product Cb 101 (NDC 71160-191). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - active ingredient, otc - purpose, indications & usage, warnings, other safety information, otc - do not use, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Active ingredients:
Octinoxate 7.5%
Oxybenzone 3.5%
Purpose:
Octinoxate ..............................Sunscreen
Oxybenzone ...........................Sunscreen
Uses:
Warnings
• Skin Cancer/Skin Aging Alert: Spending time in the sun increases your
risk of skin cancer and early skin aging. This product has been shown
only to help prevent sunburn, not skin cancer or early skin aging.
For external use only.
Other information
• Protect this product from excessive heat and direct sun
Do not use on broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask doctor: if rash or irritation develops and persists.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
• Apply liberally 15 minutes before sun exposure as needed
• Children under 6 months of age: ask a doctor before use.
• Reapply at least every 2 hours.
• Use a water resistant sunscreen if swimming or sweating.
Inactive Ingredients
Petrolatum, Ozokerite, Mineral Oil, Microcrystalline Wax, Paraffin, Lanolin,
Copernicia Cerifera (Carnauba) Wax, Tocopherol,
Propylparaben, Methylparaben, Aloe Barbadensis Leaf Extract.
Questions or comments? www.tekweld.com MADE IN USA
SPF15 Natural • Aloe Vera • Safety Sealed
Peel Back for Drug Facts
Net Wt. 0.15 oz (4.25g)
Distributed by: Tekweld 45 Rabro Dr. Hauppauge, NY 11788
res
* Please review the disclaimer below.